Study of methicillin-resistant Staphylococcus aureus on the U.S./Mexico border

Travel Medicine and Infectious Disease

Volumn 7, Issue 1, 2009, Pages 30-34

  Rivera, José O ^a,b,c   Ho, Hoi ^c   Domínguez, Delfina C ^a   Tyroch, Alan H ^c   Antony, Suresh ^c   Norte, Arturo ^a   Pérez Ruvalcaba, José Ascensión ^d  

^a UNIVERSITY OF TEXAS AT EL PASO   (United States)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^c TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^d UNIVERSIDAD AUTÓNOMA DE CIUDAD JUÁREZ   (Mexico)

Author keywords

Bacterial resistance; CA MRSA; HA MRSA; MRSA; U.S. Mexico border

Indexed keywords

CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; GATIFLOXACIN; GENTAMICIN; LEVOFLOXACIN; LINEZOLID; OXACILLIN; PANTON VALENTINE LEUKOCIDIN; RIFAMPICIN; TETRACYCLINE; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CONTROLLED STUDY; HOSPITAL; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MEXICO; MICROBIAL IDENTIFICATION; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; STAPHYLOCOCCUS INFECTION; UNITED STATES;

ANTI-BACTERIAL AGENTS; BACTERIAL TOXINS; COMMUNITY-ACQUIRED INFECTIONS; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; EXOTOXINS; HOSPITALIZATION; HUMANS; LEUKOCIDINS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MEXICO; MICROBIAL SENSITIVITY TESTS; PREVALENCE; RESPIRATORY TRACT INFECTIONS; RISK FACTORS; SOFT TISSUE INFECTIONS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCAL SKIN INFECTIONS; TEXAS;

EID: 58549105093     PISSN: 14778939     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tmaid.2008.12.005     Document Type: Article

References (17)

1. U.S. Department of Transportation. Research and Innovative Technology Administration (RITA). Available from:. http://www:Transtats.bts.gov/bordercrossing.aspx [accessed 14.02.08]
2. Couper M.R. Strategies for the rational use of antimicrobials. Clin Infect Dis 24 Suppl. 1 (1997) S154-S156
3. Centers for Disease Control (CDC). Importation permits for etiologic agents. Available from:. http://www.cdc.gov/od/ohs/biosfty/imprtper.htm [accessed 29.02.03]
4. National Committee for Clinical Laboratory Standards (NCCLS). Performance Standards for Antimicrobial Susceptibility Testing: Ninth Informational Supplement M100-S9 (1999), NCCLS, Wayne, PA
5. SAS Institute Version 9.1.3, Cary, NC; 2007.
6. Al-Haddad A.M., Udd E.E., Mokadas E.M., Sanyal S.C., and Grubb W.B. Persistance of a clone of methicillin-resistant Staphylococcus aureus in a burns unit. J Med Microbiol 50 (2001) 558-564
7. Oliveira D.C., and de Lencastre H. Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 46 7 (2002) 2155-2161
8. Wolter D.J., Tenover F.C., and Goering R.V. Allelic variation in genes encoding Panton-Valentine leukocidin from community-associated Staphylococcus aureus. Clin Microbiol Infect 13 (2007) 827-830
9. Lewis M.T., Gales A.C., Sader H.S., Pfaller M.A., and Jones R.N. Frequency of occurrence and antimicrobial susceptibility patterns for pathogens isolated from Latin American patients with diagnosis of pneumonia: results from the SENTRY antimicrobial surveillance program (1998). Diagn Microbiol Infect Dis 37 1 (2000) 63-74
10. Rivera J.O., Ortiz M., Lawson M.H., and Verma K.M. Evaluation of the use of complementary alternative medicine in the largest Mexican American border city. Pharmacotherapy 22 2 (2002) 256-264
11. Pylpa J. Self-medication practices in two California-Mexican communities. J Immigr Health 3 2 (2001) 59-75
12. de Guzman G.C., Khaleghi M., Riffenberg R.H., and Clark R.F. A survey of the use foreign-purchased medications in a border community emergency department patient population. J Emerg Med 33 2 (2007) 213-221
13. Weber S.G., Gold H.S., Hooper D.C., Karchmer A.W., and Carmeli Y. Fluoroquinolones and and the risk of methicillin-resistant Staphylococcus aureus in hospitalized patients. Emerg Infect Dis 9 11 (2003) 1415-1422
14. Graffunder E.M., and Venezia R. Risk factors associated with nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infections including previous use of antimicrobials. J Antimicrob Chemother 49 (2002) 999-1005
15. LeBlanc L., Pépin J., Toulouse K., Ouellette M.-F., Coulombe M.-A., Corriveau M.-P., and Alary M.-E. Fluoroquinolones and risk for methicillin-resistant Staphylococcus aureus, Canada. Emerg Infect Dis 12 9 (2006) 1398-1405
16. O'Brien F.G., Lim T.T., Winnett D.C., Coombs G.W., Pearson J.C., Delgado A., et al. J Clin Microbiol 43 6 (2005) 2929-2972
17. Klevens R.M., Morrison M.A., Nadle J., Petit S., Gershman K., Harrison L.H., et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 298 15 (2007) 1763-1771